Adicet Bio

Adicet Bio

Edit info

  • Founded: 2014
  • Location: Redwood City, CA
  • Employee range: 51-100
  • Clinical stage: Clin1
  • Therapy area: Non-Hodgkin's lymphoma, Lupus (FT)
  • Drug types: ONC
  • Lead product: ADI-001
  • Funding: 100-500M


adicetbio.com

linkedin.com

job board


Business:

Immunotherapies

Drug notes:

ADI-270 Clin0 renal cell carcinoma; ADI-925 Clin0 multiple cancers; ADI-002 Clin0 hepatocellular carcinoma; 3 undisclosed programs RD/Clin0 multiple cancers

About:

Adicet Bio is developing T cell therapies to treat cancer. Gamma delta T cells recognise and eliminate diseased or cancerous cells making them well suited as cancer therapies. Moreover, these cells function in a MHC-independent manner which means they can be used in non-host settings without causing graft vs. host disease reducing risk. However, gamma delta T cells comprise a small fraction of blood cells. To overcome this, Adicet is creating universal off-the-shelf genetically modified gamma delta T cells that selectively target tumors. Adicent has shown that these cells show anti-tumor activity in vitro and in vivo mouse models and are now entering clinical trials while building their broad cancer pipeline.

Adicet Bio
QC Microbiology, Specialist
Redwood City, CA|7 days ago
Apply
Adicet Bio
DIRECTOR, CLINICAL QUALITY ASSURANCE
Redwood City, CA|8 days ago
Adicet Bio
Vendor Management Specialist (Contractor)
Redwood City, CA|17 days ago
Adicet Bio
Process Development Engineer 2/3
Redwood City, CA|45 days ago


© 2025 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy

Contact: recruit@workinbiotech.com